Precise Diagnosis and Treatment for Brain Cancer CapitalBio

Features of Precise Diagnosis and Treatment for Brain Cancer

This test comprehensively detects the molecular signatures of relevant tumor drugs approved by NMPA/FDA, as well as the genes related to typing, diagnosis, prognosis and medication in NCCN/CSCO/WHO guidelines, brain tumor research and related clinical trials. Provide accurate and comprehensive evaluation for molecular typing, auxiliary diagnosis, prognosis and drug treatment of brain tumor patients.

This panel is customized by authoritative institutions - Department of Neurosurgery, Beijing Tiantan Hospital, including 4 mutant types - 52 SNVs and Indels, 25 CNVs, 8 gene fusions, and 6 co-deletions/amplifications at the chromosome level.

Newly diagnosed / recurrent brain tumor patients